| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |